Skip to main content
Medacta Group SA logo

Medacta Group SA — Investor Relations & Filings

Ticker · MOVE ISIN · CH0468525222 LEI · 506700P2PFU3A3DROC14 SW Manufacturing
Open in API
Filings indexed 199 across all filing types
Latest filing 2023-10-12 Regulatory Filings
Country CH Switzerland
Listing SW MOVE

About Medacta Group SA

https://www.medacta.com/

Medacta Group SA is a medical device company that designs, manufactures, and distributes orthopaedic and neurosurgical products worldwide. Its portfolio focuses on joint replacement, spine surgery, and sports medicine. The company emphasizes innovation in minimally invasive surgical techniques and personalized patient solutions, developed through close collaboration with surgeons. A key component of its business model is the M.O.R.E. Institute, a global medical education platform that provides comprehensive training and support for healthcare professionals. Medacta is recognized for pioneering advanced surgical approaches, such as Kinematic Alignment for total knee replacement, with a focus on improving patient outcomes and healthcare sustainability.

Recent filings

Filing Released Lang Actions
A new study confirms the accuracy of NextAR Shoulder, Medactas augmented reality surgical application
Regulatory Filings Classification · 1% confidence The document is titled 'MEDIA RELEASE' and announces the publication of a new study confirming the accuracy of a surgical application (NextAR Shoulder). It contains key highlights, quotes, and references to the study published in a journal, rather than being the full financial report (like 10-K or IR) or a formal regulatory filing summary. Since it is an announcement of news/results (a study confirmation) and not a standard financial report, it fits best under the general 'Regulatory Filings' (RNS) category as a general corporate announcement, or potentially an 'Earnings Release' (ER) if it were tied to financial performance, but here it is product/study news. Given the options, RNS serves as the best general announcement/news category for non-financial performance updates.
2023-10-12 English
A new study confirms the accuracy of NextAR Shoulder, Medacta’s augmented reality surgical application
Environmental & Social Information Classification · 1% confidence The document is explicitly labeled as a 'MEDIA RELEASE' and announces the publication of a new study confirming the accuracy of a surgical application (NextAR Shoulder). It contains company news, contact information, and boilerplate 'ABOUT' sections typical of press releases. It is not a formal regulatory filing like a 10-K, IR, or ER, nor is it an announcement of a report publication (RPA) that merely points to an attached document; rather, it is the content of the announcement itself. Since it is a general corporate announcement that doesn't fit the highly specific categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is Regulatory Filings (RNS), which serves as the general category for miscellaneous regulatory/corporate announcements not covered elsewhere.
2023-10-12 English
Medacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023
Earnings Release Classification · 1% confidence The document is explicitly titled as an 'Ad-hoc' announcement released on '22 September 2023' and reports financial results for the 'first semester 2023' (Half-Year Results). It provides key financial highlights (revenue, EBITDA margin) and an updated outlook for FY 2023. This structure—a brief announcement summarizing period results, often referencing a more comprehensive report (the '2023 Half-Year Report' mentioned in the footnotes)—is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since it contains detailed financial tables and management commentary covering a period shorter than a year (H1 2023), it fits the definition of a comprehensive financial report for a shorter period, which corresponds to the Interim / Quarterly Report (IR) category. It is not just a brief announcement of results (ER), nor is it the full Annual Report (10-K). H1 2023
2023-09-22 English
Medacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023
Earnings Release Classification · 1% confidence The document explicitly states it is an 'Ad hoc announcement pursuant to Art. 53 LR' and reports 'Half Year Results' for the 'first semester 2023'. It provides key financial highlights (revenue, adjusted EBITDA margin) and includes a table comparing performance metrics for the period ending 30.06.2023 against 30.06.2022. This content structure—a press release summarizing period results with comparative data and an outlook—is characteristic of an Earnings Release (ER). Although it covers a half-year period, which might suggest an Interim Report (IR), the format is a brief press release announcing the results, not the comprehensive, detailed report itself. Furthermore, it announces a webcast to present these results, reinforcing its nature as an initial results announcement. Since the document is a summary press release of period results, 'ER' (Earnings Release) is the most appropriate classification over 'IR' (Interim Report), which implies the full, detailed filing. H1 2023
2023-09-22 English
Medacta Group SA: 2023 Half-Year Unaudited Top-Line Figures
Earnings Release Classification · 1% confidence The document is titled "Medacta Group SA: 2023 Half-Year Unaudited Top-Line Figures" and explicitly states it is announcing the "first semester 2023 preliminary unaudited revenue." It provides detailed revenue figures for 1H 2023 compared to 1H 2022, broken down by geography and product line. This content aligns perfectly with the definition of a comprehensive financial report for a period shorter than a year. The classification code for this is 'IR' (Interim / Quarterly Report). Although it mentions the full results will be announced on September 22, 2023, this document itself contains the detailed interim financial performance data, making it the Interim Report, not just a publication announcement (RPA). H1 2023
2023-07-28 English
Medacta Group SA: 2023 Half-Year Unaudited Top-Line Figures
Earnings Release Classification · 1% confidence The document is titled 'Medacta Group SA: 2023 Half-Year Unaudited Top-Line Figures' and explicitly states it is an 'Ad hoc announcement pursuant to Art. 53 LR'. It provides preliminary, unaudited revenue figures for the first semester (1H) of 2023, including comparisons to 1H 2022, and updates the full-year outlook. This content aligns perfectly with the definition of an Interim/Quarterly Report (IR), as it covers a period shorter than a year (half-year) with comprehensive financial highlights, even though it is preliminary. It is not the full, audited 10-K, nor is it just a brief announcement of a report (RPA/RNS), as it contains substantial financial data. The mention of the full '2023 Half-Year Results' being announced later on September 22, 2023, confirms this document is the preliminary release of interim figures. H1 2023
2023-07-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.